Trial intelligence / Profile preview

Buspirone in Heroin Withdrawal

NCT00326235Phase 4Completed

Sponsor
National Institute on Drug Abuse
Start
Jan 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of buspirone in opioid withdrawal, sponsored by National Institute on Drug Abuse. Started Jan 2002; status: completed.

02

Drugs

buspirone
03

Conditions

opioid withdrawal

Beyond the preview

Go deeper on NCT00326235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00326235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call